高橋祥子

О себе

高橋祥子 is a Japanese life-science entrepreneur and researcher focused on genomics, preventive medicine, and longevity. She founded GeneQuest in 2013 while in the doctoral program at the University of Tokyo, later served as an executive officer at Euglena, and is now CEO of TAZ Inc., a longevity biotech company; TAZ’s corporate site lists the company as established in August 2020, while its public launch was announced on January 24, 2024. Public bios also list her as a visiting special professor at Tohoku University, a member of MEXT’s Science and Technology Council, a University of Tokyo management council member, and an outside director of Tohoku University Venture Partners.

Области интересов